article thumbnail

Public Health Product Hops

Bill of Health

Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. My talk was titled “Legal Approaches to Ensuring Timely Generic Drug Availability.”

article thumbnail

Is Preemption the Cure for Healthcare Federalism’s Restrictions on Medication Abortion?

Bill of Health

This post is an adaptation of an article published in the Harvard Social Impact Review. Food and Drug Administration (FDA) is now top of mind for lawyers, scholars, policymakers, and the public. The FDA first approved mifepristone, in a regimen with misoprostol, for the termination of early pregnancy in 2000. By Allison M.

FDA 176
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Publishes New Guidance on Cybersecurity in Medical Devices

McGuire Wood

Food and Drug Administration (FDA) released updated guidance regarding cybersecurity safety requirements for medical devices. To strengthen the QSR metrics, the FDA recommends implementing a secure product development framework (SPDF) to address cybersecurity risks. 27, 2023, the U.S.

FDA 52
article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. government. It is generally known that the U.S.

article thumbnail

FDA Expands Access to Mifepristone: Next Steps for Providers and Retail Pharmacies

Hall Render

Food and Drug Administration (“FDA”) released an updated Mifepristone Risk Evaluation and Mitigation Strategy (the “Mifepristone REMS Program”), which reverses the requirement that the drug be dispensed directly to a patient by certified prescriber in a clinic or a medical office (the “in-person dispensing requirement”).

FDA 40
article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

A full posting of abstracts/summaries of these articles may be found on our? Experts’ Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care. A New Way to Contain Unaffordable Medication Costs – Exercising the Government’s Existing Rights. 2022 Feb 24.

FDA 205
article thumbnail

Petrie-Flom Welcomes 2022-2023 Student Fellows

Bill of Health

She has previously published articles on synthetic biology regulation and governance, end stage renal disease payment reform, and comparative analyses of learning disorder policy. Her articles have appeared in the Indian Journal of Law and Technology , the NUJS Law Review , and the Journal of Intellectual Property Rights.

Bioethics 130